Clinical Trial Update: Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Hip Fracture Patients. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the efficacy of tranexamic acid to reduce blood loss in hip fracture patients is registered, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Biogipuzkoa Health Research Institute | Conditions: Hip Fractures | Phase 4 | Status: UNKNOWN